APO RESEARCH · REPORT
Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis
Selected research
Industry Research
Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Industry Research Report 2026
Market perspective
The global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis include Echosens, Mindray, Hisky Med and Eieling Technology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market by Company
Echosens
Mindray
Hisky Med
Eieling Technology
Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Segment by Type
Transient Elastography
Acoustic radiation force impulse (ARFI) Imaging
Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Segment by Application
Hospitals
Imaging Centers
Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Transient Elastography
- Acoustic radiation force impulse (ARFI) Imaging
Applications
- Hospitals
- Imaging Centers
Companies covered
- Echosens
- Mindray
- Hisky Med
- Eieling Technology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Size (2021-2032)
- 2.2.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales (2021-2032)
- 2.2.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Average Price (2021-2032)
- 2.3 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Transient Elastography
- 2.3.3 Acoustic radiation force impulse (ARFI) Imaging
- 2.4 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Imaging Centers
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue of Manufacturers (2021-2026)
- 3.4 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Average Price by Manufacturers (2021-2026)
- 3.5 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis, Product Type & Application
- 3.8 Global Manufacturers of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis, Established Date
- 3.9 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Echosens
- 4.1.1 Echosens Company Information
- 4.1.2 Echosens Business Overview
- 4.1.3 Echosens Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Echosens Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Product Portfolio
- 4.1.5 Echosens Recent Developments
- 4.2 Mindray
- 4.2.1 Mindray Company Information
- 4.2.2 Mindray Business Overview
- 4.2.3 Mindray Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Mindray Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Product Portfolio
- 4.2.5 Mindray Recent Developments
- 4.3 Hisky Med
- 4.3.1 Hisky Med Company Information
- 4.3.2 Hisky Med Business Overview
- 4.3.3 Hisky Med Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Hisky Med Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Product Portfolio
- 4.3.5 Hisky Med Recent Developments
- 4.4 Eieling Technology
- 4.4.1 Eieling Technology Company Information
- 4.4.2 Eieling Technology Business Overview
- 4.4.3 Eieling Technology Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Eieling Technology Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Product Portfolio
- 4.4.5 Eieling Technology Recent Developments
5 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Scenario by Region
- 5.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Region: 2021-2032
- 5.2.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Region: 2021-2026
- 5.2.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Region: 2027-2032
- 5.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Region: 2021-2032
- 5.3.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Region: 2021-2026
- 5.3.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Region: 2027-2032
- 5.4 North America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Facts & Figures by Country
- 5.4.1 North America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Country (2021-2032)
- 5.4.3 North America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Facts & Figures by Country
- 5.5.1 Europe Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Country (2021-2032)
- 5.5.3 Europe Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Facts & Figures by Country
- 5.6.1 Asia Pacific Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Facts & Figures by Country
- 5.7.1 South America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Country (2021-2032)
- 5.7.3 South America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Type (2021-2032)
- 6.1.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Market Share by Type (2021-2032)
- 6.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Type (2021-2032)
- 6.2.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Market Share by Type (2021-2032)
- 6.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Application (2021-2032)
- 7.1.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Market Share by Application (2021-2032)
- 7.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Application (2021-2032)
- 7.2.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue Market Share by Application (2021-2032)
- 7.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Value Chain Analysis
- 8.1.1 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Production Mode & Process
- 8.2 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Distributors
- 8.2.3 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Customers
9 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Analyzing Market Dynamics
- 9.1 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Industry Trends
- 9.2 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Industry Drivers
- 9.3 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Industry Opportunities and Challenges
- 9.4 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst